Work

637P Biochemical response (PSA0) and testosterone (T) recovery in Metacure, a multi-arm multi-modality (MM) therapy (tx) for very high risk localized (HRL) and low volume metastatic (LVM) prostatic adenocarcinoma

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.1150

Authors: M.Y. Teo, S. McBride, A. Gopalan, H. Benoliel, J.A. Eastham, A. Goh, R. Szmulewitz, A.K. Morgans, G. Bubley, S. Gupta, E.A. Klein, P. Nguyen, A.S. Kibel, A. Wagner, I.D. Kaplan, S.E. Eggener, S.L. Liauw, M.E. Taplin, H. Scher

Institutions: Memorial Sloan Kettering Cancer Center, University of Chicago, University of Chicago Medical Center, Northwestern University, Beth Israel Deaconess Medical Center, Cleveland Clinic, Dana-Farber Cancer Institute, Brigham and Women's Hospital

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, Pediatric Cancer Foundation

OpenAlex ID: W3203281233

FWCI: 0.143

Cites:

Cited by: 1

Related to: 10